Literature DB >> 33641079

An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH).

Taymeyah Al-Toubah1, Simona Grozinsky-Glasberg2, Jonathan Strosberg3.   

Abstract

OPINION STATEMENT: DIPNECH is caused by an idiopathic proliferation of pulmonary neuroendocrine cells which can lead to bronchiolitis and multifocal lung neuroendocrine tumors. Patients often present with chronic cough and dyspnea. Larger NETs may develop malignant potential. Somatostatin analogs can palliate chronic symptoms, particularly cough. Surgical resection can be considered for relatively large (e.g. >1 cm), progressive tumors.

Entities:  

Keywords:  DIPNECH; Diffuse Pulmonary Neuroendocrine Cell Hyperplasia; Management; Somatostatin analogs

Mesh:

Year:  2021        PMID: 33641079     DOI: 10.1007/s11864-021-00828-1

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  2 in total

1.  The expanding role of somatostatin analogs in the management of neuroendocrine tumors.

Authors:  Edward M Wolin
Journal:  Gastrointest Cancer Res       Date:  2012-09

2.  Diffuse Neuroendocrine Cell Hyperplasia: Report of Two Cases.

Authors:  Cevriye Cansız Ersöz; Ayten Kayı Cangır; Serpil Dizbay Sak
Journal:  Case Rep Pathol       Date:  2016-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.